2010 annual financial data

Nektar Therapeutics 2010 Financial results

Direct answer

Revenue was 159,039,000 USD.

Operating income was -28,255,000 USD and net income was -37,938,000 USD.
Operating cash flow was -55,871,000 USD.

Get free Nektar Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
159,039,000 USD
Operating income
-28,255,000 USD
Net income
-37,938,000 USD
Operating cash flow
-55,871,000 USD